Turnstone Biologics Corp.
TSBX
Revenue
19.31M
▲9.09M▲88.90%
6 Months ChangeAssets
76.88M
▼-17.51M▼-18.55%
3 Months ChangeLiabilities
17.14M
▲2.76M▲19.21%
3 Months ChangeFree Cash Flow
-17.60M
▲446.00k▲2.47%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-11
Form 8-K
ID: 0001193125-24-236377
2024-10-01
Form 8-K
ID: 0000950170-24-110890
2024-08-14
Form 10-Q
ID: 0000950170-24-097065
2024-08-14
Form 8-K
ID: 0000950170-24-097051
2024-06-05
Form 8-K
ID: 0000950170-24-069412
2024-05-13
Form 10-Q
ID: 0000950170-24-058818
2024-05-13
Form 8-K
ID: 0000950170-24-058812
2024-04-16
Form 8-K
ID: 0001193125-24-097060
2024-03-21
Form 8-K
ID: 0001193125-24-073985
2024-03-05
Form 8-K
ID: 0001193125-24-058731